{{dablink|DQ1 redirects here. For the first title in the ''Dragon Quest'' series, see ''[[Dragon Warrior]]''.}}
{{lead too short|date=January 2010}}
{| id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border=0 cellpadding=0 align=right width="240px"
|-
| align="center" colspan="2" |  [[Image:DQ Illustration.PNG|width|250px|Illustration of HLA-DQ with peptide in the binding pocket]]
|-
| align="center" colspan="2" | <div style="font-size:medium; line-height:120%;">major histocompatibility complex, class II, DQ1</div>
|-
| bgcolor="#e7dcc3" | Haplotypes
| bgcolor="#eeeeee" | DQA1*0101:DQB1*0501 DQA1*0101:DQB1*0502 DQA1*0102:DQB1*0502 DQA1*0104:DQB1*0503 DQA1*0103:DQB1*0601 DQA1*0102:DQB1*0602 DQA1*0103:DQB1*0603 DQA1*0102:DQB1*0604 DQA1*0102:DQB1*0605 DQA1*0102:DQB1*0609....
|-
| colspan="2" bgcolor="#dddddd" | '''Structure'''
|-style="background:#f8f8f8"
|  bgcolor="#dddddd" | '''Identifiers'''|| align="center" | <div style="font-size:medium; line-height:120%;">alpha 1 ''*0101'' ''*0102'' ''*0103'' ''*0104''</div>
|-
| bgcolor="#e7dcc3" | [[Human Genome Organisation|Symbol(s)]]
| bgcolor="#eeeeee" | [http://www.gene.ucl.ac.uk/nomenclature/data/get_data.php?hgnc_id=HGNC4942 HLA-DQA1]
|-
| bgcolor="#e7dcc3" | [[European Bioinformatics Institute|EBI-HLA]]
| bgcolor="#eeeeee" | [http://www.ebi.ac.uk/cgi-bin/imgt/hla/get_allele.cgi?DQA1*0101 DQA1*0101]
|-
| bgcolor="#e7dcc3" | [[European Bioinformatics Institute|EBI-HLA]]
| bgcolor="#eeeeee" | [http://www.ebi.ac.uk/cgi-bin/imgt/hla/get_allele.cgi?DQA1*0102 DQA1*0102]
|-
| bgcolor="#e7dcc3" | [[European Bioinformatics Institute|EBI-HLA]]
| bgcolor="#eeeeee" | [http://www.ebi.ac.uk/cgi-bin/imgt/hla/get_allele.cgi?DQA1*0103 DQA1*0103]
|-
| bgcolor="#e7dcc3" | [[European Bioinformatics Institute|EBI-HLA]]
| bgcolor="#eeeeee" | [http://www.ebi.ac.uk/cgi-bin/imgt/hla/get_allele.cgi?DQA1*0104 DQA1*0104]
|-style="background:#f8f8f8"
|  bgcolor="#dddddd" | '''Identifiers'''|| align="center" | <div style="font-size:medium; line-height:120%;">[[HLA-DQB1|beta 1]] ''*05'' or ''*06''</div>
|-
| bgcolor="#e7dcc3" | [[Human Genome Organisation|Symbol(s)]]
| bgcolor="#eeeeee" | [[HLA-DQB1]]
|-
| bgcolor="#e7dcc3" | [[European Bioinformatics Institute|EBI-HLA]]
| bgcolor="#eeeeee" | [http://www.ebi.ac.uk/cgi-bin/imgt/hla/get_allele.cgi?DQB1*05 DQB1*05]
|-
| bgcolor="#e7dcc3" | [[European Bioinformatics Institute|EBI-HLA]]
| bgcolor="#eeeeee" | [http://www.ebi.ac.uk/cgi-bin/imgt/hla/get_allele.cgi?DQB1*06 DQB1*06]
|-
| colspan="2" bgcolor="#dddddd" | '''Shared data'''
|-
| bgcolor="#e7dcc3" | [[Locus (genetics)|Locus]]
| bgcolor="#eeeeee" | [[Chromosome 6 (human)|chr.6]] ''[http://www.ncbi.nlm.nih.gov/Omim/getmap.cgi?chromosome=6p21.31 6p21.31]''
|-
|}
'''HLA-DQ1''' is a [[serotype]] that covers a broad range of [[HLA-DQ]] [[haplotype]]s. Historically it was identified as a DR-like alpha chain called DC1,<ref name="pmid6300884">{{cite journal | author = Trowsdale J, Lee J, Carey J, Grosveld F, Bodmer J, Bodmer W | title = Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 80 | issue = 7 | pages = 1972–6 | year = 1983 | pmid = 6300884 | doi =10.1073/pnas.80.7.1972 | pmc = 393734 }}</ref> later,  it was among 3 types DQw1 (later DQ1, and split into [[HLA-DQ5|DQ5]] and [[HLA-DQ6|DQ6]]), DQw2 and DQw3. Of these three serotyping specificities only DQw1 recognized DQ alpha chain.<ref name="pmid2412948">{{cite journal | author = Möller E, Carlsson B, Wallin J | title = Implication of structural class II gene polymorphism for the concept of serologic specificities | journal = Immunol. Rev. | volume = 85 | issue = | pages = 107–28 | year = 1985 | pmid = 2412948 | doi =10.1111/j.1600-065X.1985.tb01132.x }}</ref> The serotype is positive in individuals who bear the DQA1*01 alleles. The most frequently found within this group are: DQA1*0101, *0102, *0103, and *0104.
In the illustration on the right, DQ1 serotyping antibodies recognizes the DQ α (magenta), where antibodies to DQA1* gene products bind variable regions close to the peptide binding pocket.

==Serotypes==
{| border="0" cellspacing="0" cellpadding="0" align="left" style="text-align:center; background:#ffffff; margin-right: 1em; border:2px #e0e0ff solid;"
|+ Some DRB1* alleles and DQ5, DQ1, DQ6 recognition <ref>[http://www.ebi.ac.uk/imgt/hla/allele.html derived from IMGT/HLA]</ref>
|- style="background:#f0f0ff"
| style="width:60px" | DQB1* || style="width:60px" | '''DQ5'''
| style="width:60px" | DQ1 || style="width:60px" | '''DQ6''' || style="width:60px" | Sample
|- style="background:#f0f0ff"
| allele || % || % || % || size (N)
|-
| style = "background:#e8e8f8" | 0501 || 69 || 20 || 2 || 5536
|-
| style = "background:#e8e8f8" | 0502 || 48 || 24 || 15 || 919
|-
| style = "background:#e8e8f8" | 0503 || 58 || 22 || 4 || 1327
|-
| style = "background:#e8e8f8" | 0504 || 59 || 17 || 2 || 48
|-
| style = "background:#e8e8f8" |  ||  ||  || || .
|- style="background:#f0f0ff"
| style="width:60px" |  || style="width:60px" | '''DQ6'''
| style="width:60px" | DQ1 || style="width:60px" | '''DQ5''' || style="width:60px" | N
|-
| style = "background:#e8e8f8" | 0601 || 64 || 23 ||  || 675
|-
| style = "background:#e8e8f8" | 0602 || 67 || 30 || 1 || 5151
|-
| style = "background:#e8e8f8" | 0603 || 62 || 23 || 2 || 2807
|-
| style = "background:#e8e8f8" | 0604 || 59 || 27 || 2 || 1592
|-
| style = "background:#e8e8f8" | 0605 || 76 || 13 || || 358
|-
| style = "background:#e8e8f8" | 0609 || 48 || 32 || 3 || 149
|-
|}

The '''serotyping efficiency''' of DQ1 recognition relative to DQ5 and DQ6 is listed below. Since DQ1 recognizes alpha, the DQ5 and DQ6 recognition are to beta chain. Meaning that DQ1 is corecognized with DQ5 and DQ6.

The table to the left shows some of the serotyping efficiencies.
Efficient recognition of a genotyped allele approaches 100%.
Compared to DQ2 serotyping of DQB1*0201 positive individuals (98%), the efficiency of DQ1 recognition is relatively low and error prone.

For this reason DQ1 serotyping is a poor method of typing for transplantation or disease association prediction or study.
Nonetheless, it is still widely used and association purported in the literature.

==Alleles==

===DQA1*0101===
'''DQA1*0101''' is commonly linked to haplotypes of DQB1*05, the common '''DQA1*0101:DQB1*0501'''
haplotype which is part of a braoder DR1-DQ1 haplotype.

===DQA1*0102===
'''DQA1*0102''' is associated with both DR5 and DR6.

'''DQA1*0102:DQB1*0502''' has a bimodal distribution. It is found in the Philippines in high frequency and on the Mediterranean island of [[Sardinia]].

'''DQA1*0102:DQB1*0602''' is a very common haplotype in Eurasia, with higher frequency in central Asia relative to elsewhere. It is part of a European ancestral haplotype B7-DR15-DQ1 that appears to have expanded asymmetrically into Europe. The A3-B7-DR15-DQ1 haplotype indicates relationships in Eurasia that span from Korea to Ireland, indicating some common
ancestry in recent times.

'''DQA1*0102:DQB1*0604''' much less frequently found but spread widely.

===DQA1*0103===
'''DQA1*0103''' (*0103) shows a '''negative (protective) association''' with many autoimmune disease, this association is apparent in Japanese studies in the *0103:DQB1*0601 haplotype, and in Europe with the *0103:DQB1*0603 haplotype, indicating the protective effect is influenced by the alpha chain of DQ. '''DQA1*0103 is protective''' against [[Behçet's disease]],<ref name="pmid1359669">{{cite journal | author = Mizuki N | title = Association of HLA-B51 and lack of association of class II alleles with  Behçet's disease | journal = Tissue Antigens | volume = 40 | issue = 1 | pages = 22–30 | year = 1992 | pmid = 1359669 | doi =10.1111/j.1399-0039.1992.tb01953.x | author-separator = , | author2 = Ohno S | author3 = Tanaka H | display-authors = 3 | last4 = Sugimura | first4 = Kazuhito | last5 = Seki | first5 = Takeshi | last6 = Mizuki | first6 = Nobuhiko | last7 = Kera | first7 = Jiro | last8 = Inaba | first8 = Goro | last9 = Tsuji | first9 = Kimiyoshi }}</ref><ref name="pmid1358857">{{cite journal | author = Mizuki N | title = Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51 | journal = Invest. Ophthalmol. Vis. Sci. | volume = 33 | issue = 12 | pages = 3332–40 | year = 1992 | pmid = 1358857 | doi = | author-separator = , | author2 = Inoko H | author3 = Mizuki N | display-authors = 3 | last4 = Tanaka | first4 = H | last5 = Kera | first5 = J | last6 = Tsuiji | first6 = K | last7 = Ohno | first7 = S }}</ref>
[[pemphigus vulgaris]],<ref name="pmid7871526">{{cite journal | author = Niizeki H | title = HLA-DQA1, -DQB1 and -DRB1 genotyping in Japanese pemphigus vulgaris patients by the PCR-RFLP method | journal = Tissue Antigens | volume = 44 | issue = 4 | pages = 248–51 | year = 1994 | pmid = 7871526 | doi =10.1111/j.1399-0039.1994.tb02390.x | author-separator = , | author2 = Inoko H | author3 = Mizuki N | display-authors = 3 | last4 = Inamoto | first4 = Nobuko | last5 = Watababe | first5 = Kyoko | last6 = Hashimoto | first6 = Takashi | last7 = Nishikawa | first7 = Takeji }}</ref>
[[juvenile diabetes]],<ref name="pmid7821177">{{cite journal | author = Gaber SA | title = Human leukocyte antigen class II polymorphisms and genetic susceptibility of IDDM in Egyptian children | journal = Diabetes Care | volume = 17 | issue = 11 | pages = 1341–4 | year = 1994 | pmid = 7821177 | doi =10.2337/diacare.17.11.1341 | author-separator = , | author2 = Mazzola G | author3 = Berrino M | display-authors = 3 | last4 = Canale | first4 = L. | last5 = Cornaglia | first5 = M. | last6 = Ghali | first6 = I. | last7 = Sergio Curtoni | first7 = E. | last8 = Amoroso | first8 = A. }}</ref><ref name="pmid7624445">{{cite journal | author = Chuang LM | title = HLA DQA1 genotypes and its interaction with HLA DQB1 in Chinese IDDM living in Taiwan | journal = Proc. Natl. Sci. Counc. Repub. China B | volume = 19 | issue = 2 | pages = 73–9 | year = 1995 | pmid = 7624445 | doi = | author-separator = , | author2 = Jou TS | author3 = Wu HP | display-authors = 3 | last4 = Chang | first4 = HM | last5 = Tsai | first5 = WY | last6 = Hsieh | first6 = RP | last7 = Chen | first7 = KH | last8 = Lin | first8 = BJ | last9 = Tai | first9 = TY }}</ref>
steroid-sensitive [[nephrotic syndrome]],<ref name="pmid7617114">{{cite journal | author = Abe KK | title = Association of DQB1*0302 alloantigens in Japanese pediatric patients with steroid-sensitive nephrotic syndrome | journal = Nephron | volume = 70 | issue = 1 | pages = 28–34 | year = 1995 | pmid = 7617114 | doi =10.1159/000188540 | author-separator = , | author2 = Michinaga I | author3 = Hiratsuka T | display-authors = 3 | last4 = Ogahara | first4 = Satoru | last5 = Naito | first5 = Setsuya | last6 = Arakawa | first6 = Kikuo | last7 = Tsuru | first7 = Noboru | last8 = Tokieda | first8 = Keiko }}</ref>
[[myasthenia gravis]]<ref name="pmid8882423">{{cite journal | author = Hjelmström P | title = Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis | journal = Autoimmunity | volume = 22 | issue = 1 | pages = 59–65 | year = 1995 | pmid = 8882423 | doi =10.3109/08916939508995300 | author-separator = , | author2 = Giscombe R | author3 = Lefvert AK | display-authors = 3 | last4 = Pirskanen | first4 = Ritva | last5 = Kockum | first5 = Ingrid | last6 = Landin-Olsson | first6 = Mona | last7 = Sanjeevi | first7 = Carani B. }},</ref>
[[coeliac disease]]<ref name="pmid8705011">{{cite journal | author = Nieto A, Blanco Quirós A, Arranz E, Alonso Franch M, Garrote JA, Calvo C | title = Study of HLA-DQA1 alleles in celiac children | journal = Journal of Investigational Allergology and Clinical Immunology | volume = 5 | issue = 4 | pages = 209–15 | year = 1995 | pmid = 8705011 | doi = }}</ref>
[[multiple sclerosis]],<ref name="pmid9328791">{{cite journal | author = Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Ornek I, Vaughan R, Eraksoy M | title = HLA-DR and -DQ associations with multiple sclerosis in Turkey | journal = Hum. Immunol. | volume = 55 | issue = 1 | pages = 59–65 | year = 1997 | pmid = 9328791 | doi =10.1016/S0198-8859(97)00086-4 }}</ref>
chronic active [[hepatitis C]],<ref name="pmid9288598">{{cite journal | author = Höhler T | title = MHC class II genes influence the susceptibility to chronic active hepatitis C | journal = J. Hepatol. | volume = 27 | issue = 2 | pages = 259–64 | year = 1997 | pmid = 9288598 | doi =10.1016/S0168-8278(97)80169-9 | author-separator = , | author2 = Gerken G | author3 = Notghi A | display-authors = 3 | last4 = Knolle | first4 = P | last5 = Lubjuhn | first5 = R | last6 = Taheri | first6 = H | last7 = Schneider | first7 = PM | last8 = Meyer Zum Büschenfelde | first8 = KH | last9 = Rittner | first9 = C }}</ref> and [[Vogt-Koyanagi-Harada syndrome]].<ref name="pmid10682969">{{cite journal | author = Kim MH | title = Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans | journal = Am. J. Ophthalmol. | volume = 129 | issue = 2 | pages = 173–7 | year = 2000 | pmid = 10682969 | doi =10.1016/S0002-9394(99)00434-1 | author-separator = , | author2 = Seong MC | author3 = Kwak NH | display-authors = 3 | last4 = Yoo | first4 = Jin-Seong | last5 = Huh | first5 = Warne | last6 = Kim | first6 = Tai-Gyu | last7 = Han | first7 = Hoon }}</ref>
However, it may predispose carriers to chronic infection such as [[leprosy]],<ref name="pmid8284786">{{cite journal | author = Rani R, Fernandez-Vina MA, Zaheer SA, Beena KR, Stastny P | title = Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India | journal = Tissue Antigens | volume = 42 | issue = 3 | pages = 133–7 | year = 1993 | pmid = 8284786 | doi =10.1111/j.1399-0039.1993.tb02179.x }}</ref> [[Helicobacter pylori-positive gastric lymphoma|''Helicobacter pylori''-positive gastric lymphoma]],<ref name="pmid16234023">{{cite journal | author = Kawahara Y | title = HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma | journal = Clin. Gastroenterol. Hepatol. | volume = 3 | issue = 9 | pages = 865–8 | year = 2005 | pmid = 16234023 | doi =10.1016/S1542-3565(05)00185-0 | author-separator = , | author2 = Mizuno M | author3 = Yoshino T | display-authors = 3 | last4 = Yokota | first4 = K | last5 = Oguma | first5 = K | last6 = Okada | first6 = H | last7 = Fujiki | first7 = S | last8 = Shiratori | first8 = Y }}</ref> and
[[AIDS]].<ref name="pmid7755916">{{cite journal | author = Kroner BL, Goedert JJ, Blattner WA, Wilson SE, Carrington MN, Mann DL | title = Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies | journal = AIDS | volume = 9 | issue = 3 | pages = 275–80 | year = 1995 | pmid = 7755916 | doi =10.1097/00002030-199509030-00009 }}</ref>

'''DQA1*0103:DQB1*0601''' is part of a multigene haplotype (DRB1*1502:DRB5*0102:DQA1*0103:DQB1*0601:DPA1*02:DPB1*0901) linked to [[Takayasu arteritis]] in Japanese.<ref name="pmid1360976">{{cite journal | author = Dong RP, Kimura A, Numano F, Nishimura Y, Sasazuki T | title = HLA-linked susceptibility and resistance to Takayasu arteritis | journal = Heart and vessels.  Supplement | volume = 7 | issue = | pages = 73–80 | year = 1992 | pmid = 1360976 | doi =10.1007/BF01744548 }}</ref> Another haplotype, DR8-DQ1 which contains this haplotype may be associated with [[primary biliary cirrhosis]],<ref name="pmid7699227">{{cite journal | author = Onishi S | title = DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis | journal = J. Hepatol. | volume = 21 | issue = 6 | pages = 1053–60 | year = 1994 | pmid = 7699227 | doi =10.1016/S0168-8278(05)80617-8 | author-separator = , | author2 = Sakamaki T | author3 = Maeda T | display-authors = 3 | last4 = Iwamura | first4 = S | last5 = Tomita | first5 = A | last6 = Saibara | first6 = T | last7 = Yamamoto | first7 = Y }}</ref> [[Grave's disease]]<ref name="pmid7704083">{{cite journal | author = Katsuren E, Awata T, Matsumoto C, Yamamoto K | title = HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ | journal = Endocr. J. | volume = 41 | issue = 6 | pages = 599–603 | year = 1994 | pmid = 7704083 | doi = }}</ref>
There is a '''negative association''' of this DR15-DQ1 haplotype in Japanese with [[inflammatory bowel disease]].<ref name="pmid10323339">{{cite journal | author = Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T | title = HLA class II alleles in Japanese patients with inflammatory bowel disease | journal = Tissue Antigens | volume = 53 | issue = 4 Pt 1 | pages = 350–8 | year = 1999 | pmid = 10323339 | doi =10.1034/j.1399-0039.1999.530405.x }}</ref>

'''DQA1*0103:DQB1*0603''' is part of a DR-DQ haplotype (DR13-DQ1) that increases for primary sclerosing cholangitis<ref name="pmid7875491">{{cite journal | author = Olerup O, Olsson R, Hultcrantz R, Broome U | title = HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis | journal = Gastroenterology | volume = 108 | issue = 3 | pages = 870–8 | year = 1995 | pmid = 7875491 | doi =10.1016/0016-5085(95)90463-8 }}</ref><ref name="pmid10372541">{{cite journal | author = Spurkland A | title = HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations | journal = Tissue Antigens | volume = 53 | issue = 5 | pages = 459–69 | year = 1999 | pmid = 10372541 | doi =10.1034/j.1399-0039.1999.530502.x | author-separator = , | author2 = Saarinen S | author3 = Boberg KM | display-authors = 3 | last4 = Mitchell | first4 = S. | last5 = Broome | first5 = U. | last6 = Caballeria | first6 = L. | last7 = Ciusani | first7 = E. | last8 = Chapman | first8 = R. | last9 = Ercilla | first9 = G. }}</ref> The same haplotype shows a '''negative association''' with rheumatic heart disease,<ref name="pmid10351973">{{cite journal | author = Guédez Y | title = HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients | journal = Circulation | volume = 99 | issue = 21 | pages = 2784–90 | year = 1999 | pmid = 10351973 | doi = | author-separator = , | author2 = Kotby A | author3 = El-Demellawy M | display-authors = 3 | last4 = Galal | first4 = A | last5 = Thomson | first5 = G | last6 = Zaher | first6 = S | last7 = Kassem | first7 = S | last8 = Kotb | first8 = M }}</ref>

===DQA1*0104===
'''DQA1*0104:DQB1*0503''' is part of a multigene haplotype DR14-DQ5 that is associated with MuSK positive Myasthenia gravis.

==References==
{{reflist}}
{{DQ serotypes}}

{{DEFAULTSORT:Hla-Dq1}}
[[Category:HLA-DQ haplotypes|1]]